Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Burger

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Clinical Pharmacokinetics|May 17, 2022
Prediction of Maternal and Fetal Doravirine Exposure by Integrating Physiologically Based Pharmacokinetic Modeling and Human Placenta Perfusion ExperimentsV E Bukkems, H van Hove, D Roelofsen, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
Pharmacokinetics of indinavir combined with low-dose ritonavir in human immunodeficiency virus type 1-infected childrenA S Bergshoeff, P L A Fraaij, A M C van Rossum, et al.
The Journal of Antimicrobial Chemotherapy|August 21, 2014
Pharmacokinetics of caspofungin in ICU patientsE W Muilwijk, J A Schouten, H J van Leeuwen, et al.
AIDS (London, England)|July 14, 2000
Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavirR M van Praag, G J Weverling, P Portegies, et al.
The Journal of Antimicrobial Chemotherapy|August 24, 2018
Pharmacokinetics of extended dose intervals of micafungin in haematology patients: optimizing antifungal prophylaxisE W Muilwijk, J A Maertens, W J F M van der Velden, et al.
ESMO Open|January 5, 2023
Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugsJ K Overbeek, R Ter Heine, H M W Verheul, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2015
Exposure to total and protein-unbound rifampin is not affected by malnutrition in Indonesian tuberculosis patientsL H M te Brake, R Ruslami, H Later-Nijland, et al.
The Netherlands Journal of Medicine|September 17, 2013
Treatment of hepatitis C monoinfection in adults--Dutch national guidelinesM H Lamers, M M T J Broekman, C A Boucher, et al.
Clinical Pharmacology and Therapeutics|January 10, 2008
Effect of an antiretroviral regimen containing ritonavir boosted lopinavir on intestinal and hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected patientsC Wyen, U Fuhr, D Frank, et al.
International Journal of Antimicrobial Agents|July 3, 2014
Population pharmacokinetics and limited sampling strategy for first-line tuberculosis drugs and moxifloxacinC Magis-Escurra, H M J Later-Nijland, J W C Alffenaar, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Clinical Pharmacokinetics|May 17, 2022
Prediction of Maternal and Fetal Doravirine Exposure by Integrating Physiologically Based Pharmacokinetic Modeling and Human Placenta Perfusion ExperimentsV E Bukkems, H van Hove, D Roelofsen, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
Pharmacokinetics of indinavir combined with low-dose ritonavir in human immunodeficiency virus type 1-infected childrenA S Bergshoeff, P L A Fraaij, A M C van Rossum, et al.
The Journal of Antimicrobial Chemotherapy|August 21, 2014
Pharmacokinetics of caspofungin in ICU patientsE W Muilwijk, J A Schouten, H J van Leeuwen, et al.
AIDS (London, England)|July 14, 2000
Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavirR M van Praag, G J Weverling, P Portegies, et al.
The Journal of Antimicrobial Chemotherapy|August 24, 2018
Pharmacokinetics of extended dose intervals of micafungin in haematology patients: optimizing antifungal prophylaxisE W Muilwijk, J A Maertens, W J F M van der Velden, et al.
ESMO Open|January 5, 2023
Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugsJ K Overbeek, R Ter Heine, H M W Verheul, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2015
Exposure to total and protein-unbound rifampin is not affected by malnutrition in Indonesian tuberculosis patientsL H M te Brake, R Ruslami, H Later-Nijland, et al.
The Netherlands Journal of Medicine|September 17, 2013
Treatment of hepatitis C monoinfection in adults--Dutch national guidelinesM H Lamers, M M T J Broekman, C A Boucher, et al.
Clinical Pharmacology and Therapeutics|January 10, 2008
Effect of an antiretroviral regimen containing ritonavir boosted lopinavir on intestinal and hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected patientsC Wyen, U Fuhr, D Frank, et al.
International Journal of Antimicrobial Agents|July 3, 2014
Population pharmacokinetics and limited sampling strategy for first-line tuberculosis drugs and moxifloxacinC Magis-Escurra, H M J Later-Nijland, J W C Alffenaar, et al.
Pageof 14